ArticleMedicine2026
Association between the dietary index for gut microbiota and gallstone disease: A cross-sectional analysis considering the Dietary Inflammatory Index.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The dietary index for gut microbiota (DI-GM) reflects dietary patterns that may support or adversely affect gut microbial health. This study examined the association between DI-GM and prevalence of gallstone disease (GSD), while additionally exploring the potential mediating association of the Dietary Inflammatory Index (DII), using data from the National Health and Nutrition Examination Survey 2017-2020. This cross-sectional study analyzed 5669 adults from National Health and Nutrition Examination Survey 2017-2020. GSD status was defined by self-reported physician diagnosis. DI-GM scores were calculated from 14 dietary components categorized as beneficial or detrimental to gut microbiota. DII scores were derived from nutrient intake data. Associations were evaluated using multivariable logistic regression. Higher DI-GM scores were associated with a lower likelihood of GSD (adjusted odds ratio [OR] = 0.92, 95% confidence interval [CI]: 0.87-0.97, P = .004). Individuals with DI-GM ≥ 6 had significantly reduced GSD risk (adjusted OR = 0.71, 95% CI: 0.55-0.91, P = .007). The beneficial dietary component was inversely associated with GSD (adjusted OR = 0.93, 95% CI: 0.86-0.99, P = .047). No significant interactions were observed across subgroups. Mediation analysis showed an inverse association between DI-GM and DII, with a small but significant indirect association (approximately 28%). Higher DI-GM scores are associated with a lower prevalence of GSD. These findings suggest a potential role of dietary inflammatory in this association; however, given the simultaneous measurement of exposure, mediator, and outcome, the results should be interpreted with caution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.